GB0000482D0 - Enteric coated pharmaceutical formulation - Google Patents

Enteric coated pharmaceutical formulation

Info

Publication number
GB0000482D0
GB0000482D0 GB0000482A GB0000482A GB0000482D0 GB 0000482 D0 GB0000482 D0 GB 0000482D0 GB 0000482 A GB0000482 A GB 0000482A GB 0000482 A GB0000482 A GB 0000482A GB 0000482 D0 GB0000482 D0 GB 0000482D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
enteric coated
coated pharmaceutical
enteric
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0000482A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Priority to GB0000482A priority Critical patent/GB0000482D0/en
Publication of GB0000482D0 publication Critical patent/GB0000482D0/en
Priority to EP01900496A priority patent/EP1185250A2/en
Priority to PCT/GB2001/000072 priority patent/WO2001051031A2/en
Priority to AU25326/01A priority patent/AU2532601A/en
Ceased legal-status Critical Current

Links

GB0000482A 2000-01-11 2000-01-11 Enteric coated pharmaceutical formulation Ceased GB0000482D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0000482A GB0000482D0 (en) 2000-01-11 2000-01-11 Enteric coated pharmaceutical formulation
EP01900496A EP1185250A2 (en) 2000-01-11 2001-01-10 Enteric coated pharmaceutical formulation
PCT/GB2001/000072 WO2001051031A2 (en) 2000-01-11 2001-01-10 Enteric coated pharmaceutical formulation
AU25326/01A AU2532601A (en) 2000-01-11 2001-01-10 Enteric coated pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0000482A GB0000482D0 (en) 2000-01-11 2000-01-11 Enteric coated pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB0000482D0 true GB0000482D0 (en) 2000-03-01

Family

ID=9883444

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0000482A Ceased GB0000482D0 (en) 2000-01-11 2000-01-11 Enteric coated pharmaceutical formulation

Country Status (4)

Country Link
EP (1) EP1185250A2 (en)
AU (1) AU2532601A (en)
GB (1) GB0000482D0 (en)
WO (1) WO2001051031A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1962839A4 (en) 2005-11-14 2010-08-25 Ariad Pharma Inc Administration of mntor inhibitor to treat patients with cancer
CN103330694A (en) 2006-11-14 2013-10-02 阿里亚德医药股份有限公司 Oral formulations
WO2019072877A1 (en) * 2017-10-10 2019-04-18 Capsugel Belgium Nv Gelling multiparticulates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07509702A (en) * 1992-08-05 1995-10-26 エフ・エイチ・フォールディング・アンド・カンパニー・リミテッド pellet drug composition
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
GB9814214D0 (en) * 1998-07-01 1998-09-02 Norton Healthcare Ltd Enteric coated pharmaceutical formulation

Also Published As

Publication number Publication date
AU2532601A (en) 2001-07-24
WO2001051031A3 (en) 2001-12-27
WO2001051031A2 (en) 2001-07-19
EP1185250A2 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
IL156716A0 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
PL366432A1 (en) Pharmaceutical formulation
IL161306A0 (en) Pharmaceutical formulation comprising (r)-bicalutamide
GB9909154D0 (en) Pharmaceutical formulation
GB0000482D0 (en) Enteric coated pharmaceutical formulation
GB2353215B (en) New aqueous enteric coating formulations
GB0014851D0 (en) Novel pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB0014883D0 (en) Novel pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB9814214D0 (en) Enteric coated pharmaceutical formulation
GB0104749D0 (en) Pharmaceutical formulation
EP1414417A4 (en) Pharmaceutical formulation
GB0014849D0 (en) Pharmaceutical aerosol formulation
GB0014869D0 (en) Novel pharmaceutical formulation
AU2002321707A8 (en) Pharmaceutical enteric coated composition comprising chitosan
GB0014451D0 (en) Pharmaceutical formulation
GB0019084D0 (en) Pharmaceutical formulation
GB0014424D0 (en) Pharmaceutical formulation
GB0018654D0 (en) Pharmaceutical formulation
GB0018686D0 (en) Pharmaceutical formulation
GB0019840D0 (en) Novel pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)